241 related articles for article (PubMed ID: 25121994)
1. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.
Veerman SR; Schulte PF; Begemann MJ; de Haan L
Pharmacopsychiatry; 2014 Nov; 47(7):231-8. PubMed ID: 25121994
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.
Doruk A; Uzun O; Ozşahin A
Int Clin Psychopharmacol; 2008 Jul; 23(4):223-7. PubMed ID: 18545061
[TBL] [Abstract][Full Text] [Related]
3. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.
Josiassen RC; Joseph A; Kohegyi E; Stokes S; Dadvand M; Paing WW; Shaughnessy RA
Am J Psychiatry; 2005 Jan; 162(1):130-6. PubMed ID: 15625211
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
Taylor DM; Smith L
Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
[TBL] [Abstract][Full Text] [Related]
6. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Scimeca G; Di Nardo F; Santoro V; Spina E; Zoccali RA
Schizophr Res; 2011 Apr; 127(1-3):93-9. PubMed ID: 21262565
[TBL] [Abstract][Full Text] [Related]
7. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
8. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
Vayısoğlu S; Anıl Yağcıoğlu E
Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
[TBL] [Abstract][Full Text] [Related]
9. Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial.
Freudenreich O; Henderson DC; Walsh JP; Culhane MA; Goff DC
Schizophr Res; 2007 May; 92(1-3):90-4. PubMed ID: 17321111
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review.
Sommer IE; Begemann MJ; Temmerman A; Leucht S
Schizophr Bull; 2012 Sep; 38(5):1003-11. PubMed ID: 21422107
[TBL] [Abstract][Full Text] [Related]
11. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
12. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia.
Chiu YH; Hsu CY; Lu ML; Chen CH
Curr Pharm Des; 2020; 26(2):218-227. PubMed ID: 31924152
[TBL] [Abstract][Full Text] [Related]
13. Clozapine resistance: augmentation strategies.
Porcelli S; Balzarro B; Serretti A
Eur Neuropsychopharmacol; 2012 Mar; 22(3):165-82. PubMed ID: 21906915
[TBL] [Abstract][Full Text] [Related]
14. [Augmentation of Clozapine With Paliperidone in Schizophrenia Patients With Partial Response to Treatment: A Case Series].
Kalenderoğlu A; Çelik M
Turk Psikiyatri Derg; 2016; 27(1):57-62. PubMed ID: 27369686
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of clozapine with a second antipsychotic - a meta-analysis.
Taylor DM; Smith L; Gee SH; Nielsen J
Acta Psychiatr Scand; 2012 Jan; 125(1):15-24. PubMed ID: 22077319
[TBL] [Abstract][Full Text] [Related]
16. Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis.
Paton C; Whittington C; Barnes TR
J Clin Psychopharmacol; 2007 Apr; 27(2):198-204. PubMed ID: 17414246
[TBL] [Abstract][Full Text] [Related]
17. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
18. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
[TBL] [Abstract][Full Text] [Related]
20. Does adding a second antipsychotic to clozapine improve clinical response in resistant schizophrenia?
Jiménez-Cornejo M; Munizaga G; Aceituno D
Medwave; 2016 Dec; 16(Suppl5):e6614. PubMed ID: 27922589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
